002019 億帆醫藥
按盤價 
12.180 +0.040 (+0.329%)
12.180 +0.040 (+0.329%) | 2024/09 - 九個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 4.365 | -6.450 | 2.205 | 3.280 | 12.151 |
| 總資產報酬率 ROA (%) | 3.070 | -4.584 | 1.548 | 2.339 | 8.531 |
| 投入資產回報率 ROIC (%) | 3.380 | -5.054 | 1.707 | 2.591 | 9.643 | 邊際利潤分析 |
| 銷售毛利率 (%) | 47.647 | 47.840 | 48.635 | 41.469 | 46.477 |
| 營業利潤率 (%) | 9.943 | -21.698 | 3.748 | 4.813 | 20.083 |
| 息稅前利潤/營業總收入 (%) | 11.272 | -19.916 | 4.665 | 6.419 | 21.258 |
| 淨利潤/營業總收入 (%) | 7.977 | -21.771 | 3.312 | 5.494 | 17.247 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 84.746 | -3.012 | 118.914 | 106.878 | 89.171 |
| 價值變動淨收益/利潤總額(%) | -1.800 | 1.733 | -11.250 | -2.130 | 0.642 |
| 營業外收支淨額/利潤總額(%) | 0.370 | -1.574 | 8.249 | -0.668 | -0.356 | 償債能力分析 |
| 流動比率 (X) | 1.316 | 1.486 | 1.678 | 1.558 | 1.647 |
| 速動比率 (X) | 0.959 | 1.062 | 1.300 | 1.269 | 1.373 |
| 資產負債率 (%) | 31.936 | 28.216 | 27.083 | 27.871 | 0.250 |
| 帶息債務/全部投入資本 (%) | 21.750 | 18.593 | 19.214 | 19.673 | 15.838 |
| 股東權益/帶息債務 (%) | 348.999 | 425.239 | 404.494 | 391.875 | 511.385 |
| 股東權益/負債合計 (%) | 215.497 | 255.052 | 259.376 | 251.733 | 290.328 |
| 利息保障倍數 (X) | 8.724 | -13.772 | 8.048 | 3.919 | 17.052 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 86.164 | 101.414 | 105.968 | 85.022 | 65.015 |
| 存貨周轉天數 (天) | 133.210 | 149.262 | 136.536 | 87.028 | 73.610 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 18/11/2024 11:54 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
